Pheochromocytoma as a catecholamine producing tumor: implications for clinical practice (Q36827287)

16 August 2017

1 reference

title

Pheochromocytoma as a catecholamine producing tumor: implications for clinical practice (English)

1 reference

16 August 2017

1 reference

T Zelinka

1

1 reference

PubMed ID

17514588

16 August 2017

G Eisenhofer

series ordinal

2

1 reference

PubMed ID

17514588

16 August 2017

K Pacak

series ordinal

3

1 reference

16 August 2017

1 June 2007

1 reference

16 August 2017

1 reference

16 August 2017

10

1 reference

16 August 2017

2

1 reference

16 August 2017

195-203

1 reference

Malignant pheochromocytoma: state of the field with future projections

16 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Genetic testing in pheochromocytoma or functional paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Pheochromocytoma: clinical observations from a Brooklyn tertiary hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Diabetes as a marker of pheochromocytoma in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Genetic testing in pheochromocytoma: increasing importance for clinical decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Pheochromocytoma: state-of-the-art and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Pheochromocytoma as an endocrine emergency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Malignant pheochromocytoma: current status and initiatives for future progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Phaeochromocytoma, new genes and screening strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Management of the clinically inapparent adrenal mass ("incidentaloma")

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Pheochromocytomas: can malignant potential be predicted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

1,111 patients with adrenal incidentalomas observed at a single endocrinological center: incidence of chromaffin tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Mortality associated with pheochromocytoma: increased risk for additional tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Perioperative management of pheochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Effects of slow-release octreotide on urinary metanephrine excretion and plasma chromogranin A and catecholamine levels in patients with malignant or recurrent phaeochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Malignant pheochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Biochemical diagnosis of pheochromocytoma: which test is best?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Management and treatment of pheochromocytomas and paragangliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Pheochromocytoma in Italy: a multicentric retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Clinical spectrum and outcome of functional extraadrenal paraganglioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Genotype-phenotype correlations in von Hippel-Lindau disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Images in cardiovascular medicine. Unusual case of pheochromocytoma with a surprising response to the intravenous administration of norepinephrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Phaeochromocytoma--recent progress in its management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

CT and MR imaging of unusual locations of extra-adrenal paragangliomas (pheochromocytomas).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Intraoperative haemodynamic stability in patients with phaeochromocytoma ? minimally invasive vs conventional open surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Analysis of large versus small pheochromocytomas: operative approaches and patient outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Increased blood pressure variability in pheochromocytoma compared to essential hypertension patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

Production, characterization, and expression of neuropeptide Y by human pheochromocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890701395896

10.1080/10253890701395896

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17514588